Development of a novel polyethylene glycol-corticosteroid-conjugate with an acid-cleavable linker

References

• Becker M. (2008). Identification of a Cathepsin B-mediated cell death pathway in thymocytes with impact on negative selection. PhD-Thesis. University Heidelberg. http://www.ub.uni-heidelberg.de/archiv/8615.
   Google Scholar
• Bernstein A, Hurwitz E, Maron R, Arnon R, Sela M, Wilchek M. (1978). Higher antitumor efficacy of daunomycin when linked to dextran: in vivo and in vitro studies. J Natl Cancer Inst, 60, 379–384.
   PubMed Web of Science ®Google Scholar
• Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. (1993). Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med, 119, 1198–1208.
   PubMed Web of Science ®Google Scholar
• Chen B, Li M, Lin M, Tumambac G, Rustum A. (2009). A comparative study of enol aldehyde formation from betamethasone, dexamethasone, beclomethasone and related compounds under acidic and alkaline conditions. Steroids, 74, 30–41.
   PubMed Web of Science ®Google Scholar
• Conover CD, Zhao H, Longley CB, Shum KL, Greenwald RB. (2003). Utility of poly(ethylene glycol) conjugation to create prodrugs of amphotericin B. Bioconjug Chem, 14, 661–666.
   PubMed Web of Science ®Google Scholar
• Danhauser-Riedl S, Hausmann E, Schick HD, Bender R, Dietzfelbinger H, Rastetter J, Hanauske AR. (1993). Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD). Invest New Drugs, 11, 187–195.
   PubMed Web of Science ®Google Scholar
• Dekker D. (1979). Stability of corticosteroids under anaerobic conditions. I. 17-deoxyprednisolone. Pharmaceutisch Weekblad Scientific Edition. Netherlands: Springer, 1, 712–719.
   Google Scholar
• Duggan ST, Keam SJ. (2009). Certolizumab pegol: in rheumatoid arthritis. BioDrugs, 23, 407–417.
   PubMed Web of Science ®Google Scholar
• Duncan R. (2009). Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt. Adv Drug Deliv Rev, 61, 1131–1148.
   PubMed Web of Science ®Google Scholar
• Fiehn C, Müller-Ladner U, Gay S, Krienke S, Freudenberg-Konrad S, Funk J, Ho AD, Sinn H, Wunder A. (2004a). Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX. Rheumatology (Oxford), 43, 1097–1105.
   PubMed Web of Science ®Google Scholar
• Fiehn C, Neumann E, Wunder A, Krienke S, Gay S, Müller-Ladner U. (2004b). Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo. Ann Rheum Dis, 63, 884–886.
   PubMed Web of Science ®Google Scholar
• Fiehn C, Kratz F, Sass G, Müller-Ladner U, Neumann E. (2008). Targeted drug-delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis. Ann Rheum Dis, 67, 1188–1191.
   PubMed Web of Science ®Google Scholar
• Greenwald RB, Choe YH, McGuire J, Conover CD. (2003). Effective drug-delivery by PEGylated drug conjugates. Adv Drug Deliv Rev, 55, 217–250.
   PubMed Web of Science ®Google Scholar
• Haag R, Kratz F. (2006). Polymer therapeutics: concepts and applications. Angew Chem Int Ed Engl, 45, 1198–1215.
   PubMed Web of Science ®Google Scholar
• Haynes RC. (1992). Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. The Pharmacological Basis of Therapeutics. Vol. II, Singapore: Mc Graw-Hill Book Co, 1431.
   Google Scholar
• Iwai K, Maeda H, Konno T. (1984). Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res, 44, 2115–2121.
   PubMed Web of Science ®Google Scholar
• Jain RK. (1990a). Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res, 50, 814s–819s.
   PubMed Web of Science ®Google Scholar
• Jain RK. (1990b). Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev, 9, 253–266.
   PubMed Web of Science ®Google Scholar
• Jain RK. (1998). Delivery of molecular and cellular medicine to solid tumors. J Control Release, 53, 49–67.
   PubMed Web of Science ®Google Scholar
• Krammer PH, Citronbaum R, Read SE, Forni L, Lang R. (1976). Murine thymic lymphomas as model tumors for T-cell studies. T-cell markers, immunoglobulin and Fc-receptors on AKR thymomas. Cell Immunol, 21, 97–111.
   PubMed Web of Science ®Google Scholar
• Kratz F, Beyer U, Schütte MT. (1999). Drug-polymer conjugates containing acid-cleavable bonds. Crit Rev Ther Drug Carrier Syst, 16, 245–288.
   PubMed Web of Science ®Google Scholar
• Levick JR. (1990). Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure. J Rheumatol, 17, 579–582.
   PubMed Web of Science ®Google Scholar
• Liu XM, Quan LD, Tian J, Alnouti Y, Fu K, Thiele GM, Wang D. (2008). Synthesis and evaluation of a well-defined HPMA copolymer-dexamethasone conjugate for effective treatment of rheumatoid arthritis. Pharm Res, 25, 2910–2919.
   PubMed Web of Science ®Google Scholar
• Lorenz H-M. (2003). Molekulare grundlagen der behandlung rheumatischer erkrankungen. In: Ganten D, Ruckpaul K, Gay S, Kalden JR, eds. Molekularmedizinische Grundlagen von rheumatischen Erkrankungen. Heidelberg: Springer Verlag, 237.
   Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. (2000). Tumor vascular permeability and the EPR-effect in macromolecular therapeutics: a review. J Control Release, 65, 271–284.
   PubMed Web of Science ®Google Scholar
• Manz B, Grill HJ, Pollow K. (1982). Steroid side-chain modification and receptor affinity: binding of synthetic derivatives of corticoids to human spleen tumor and rat liver glucocorticoid receptors. J Steroid Biochem, 17, 335–342.
   PubMedGoogle Scholar
• Matsumura Y, Maeda H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res, 46, 6387–6392.
   PubMed Web of Science ®Google Scholar
• Mellman I, Fuchs R, Helenius A. (1986). Acidification of the endocytic and exocytic pathways. Annu Rev Biochem, 55, 663–700.
   PubMed Web of Science ®Google Scholar
• Melmed GY, Targan SR, Yasothan U, Hanicq D, Kirkpatrick P. (2008). Certolizumab pegol. Nat Rev Drug Discov, 7, 641–642.
   PubMed Web of Science ®Google Scholar
• Midelfart A, Dybdahl A, MUller N, Sitter B, Gribbestad IS, Krane J. (1998). Dexamethasone and dexamethasone phosphate detected by 1H and 19F NMR spectroscopy in the aqueous humour. Exp Eye Res, 66, 327–337.
   PubMed Web of Science ®Google Scholar
• Multani AS, Li C, Ozen M, Yadav M, Yu DF, Wallace S, Pathak S. (1997). Paclitaxel and water-soluble poly (l-glutamic acid)-paclitaxel, induce direct chromosomal abnormalities and cell death in a murine metastatic melanoma cell line. Anticancer Res, 17, 4269–4274.
   PubMed Web of Science ®Google Scholar
• Ohkuma S, Poole B. (1981). Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J Cell Biol, 90, 656–664.
   PubMed Web of Science ®Google Scholar
• Poole B, Ohkuma S. (1981). Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J Cell Biol, 90, 665–669.
   PubMed Web of Science ®Google Scholar
• Putnam D, Kopecek J. (1995). Polymer conjugates with anticancer activity. Advances in Polymer Science. Berlin/Heidelberg: Springer, 55.
   Google Scholar
• Richardson SC, Wallom KL, Ferguson EL, Deacon SP, Davies MW, Powell AJ, Piper RC, Duncan R. (2008). The use of fluorescence microscopy to define polymer localisation to the late endocytic compartments in cells that are targets for drug-delivery. J Control Release, 127, 1–11.
   PubMed Web of Science ®Google Scholar
• Rodrigues PC, Beyer U, Schumacher P, Roth T, Fiebig HH, Unger C, Messori L, Orioli P, Paper DH, Mulhaupt R, Kratz F. (1999). Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution. Bioorg Med Chem, 7, 2517–2524.
   PubMed Web of Science ®Google Scholar
• Seymour LW, Miyamoto Y, Maeda H, Brereton M, Strohalm J, Ulbrich K, Duncan R. (1995). Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. Eur J Cancer, 31A, 766–770.
   PubMed Web of Science ®Google Scholar
• Stella VJ, Charman WN, Naringrekar VH. (1985). Prodrugs. Do they have advantages in clinical practice? Drugs, 29, 455–473.
   PubMed Web of Science ®Google Scholar
• Stellato C. (2004). Post-transcriptional and nongenomic effects of glucocorticoids. Proc Am Thorac Soc, 1, 255–263.
   PubMedGoogle Scholar
• Szekely JG, Lobreau AU, Einspenner M, Raaphorst GP. (1987). The use of flow cytometry to measure glucocorticoid-induced killing of lymphoid cell lines. Basic Appl Histochem, 31, 153–164.
   PubMedGoogle Scholar
• van den Berg F. (2003). Synovial fluid. In: Applied Physiology (PP. 142). Vol. 1. Stuttgart: Georg Thieme Verlag.
   Google Scholar
• Wang D, Miller SC, Liu XM, Anderson B, Wang XS, Goldring SR. (2007). Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis Res Ther, 9, R2.
   PubMed Web of Science ®Google Scholar
• Wilson VS, Bobseine K, Lambright CR, Gray LE Jr. (2002). A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicol Sci, 66, 69–81.
   PubMed Web of Science ®Google Scholar
• Wunder A, Müller-Ladner U, Stelzer EH, Funk J, Neumann E, Stehle G, Pap T, Sinn H, Gay S, Fiehn C. (2003). Albumin-based drug-delivery as novel therapeutic approach for rheumatoid arthritis. J Immunol, 170, 4793–4801.
   PubMed Web of Science ®Google Scholar
• Zacchigna M, Cateni F, Di LG, Voinovich D, Perissutti B, Drioli S, Bonora GM. (2008). Synthesis of a new mPEG-dexamethasone conjugate and preliminary bioavailability studies in rabbits. J Drug Del Sci Tech, 18, 155–159.
   Web of Science ®Google Scholar
• Zunino F, Giuliani F, Savi G, Dasdia T, Gambetta R. (1982). Antitumor activity of daunorubicin linked to poly-l-aspartic acid. Int J Cancer, 30, 465–470.
   PubMed Web of Science ®Google Scholar